GB1101458A - Synergistic pharmaceutical compositions comprising local anaesthetics, myotic and neurotropic drugs - Google Patents
Synergistic pharmaceutical compositions comprising local anaesthetics, myotic and neurotropic drugsInfo
- Publication number
- GB1101458A GB1101458A GB1192665A GB1192665A GB1101458A GB 1101458 A GB1101458 A GB 1101458A GB 1192665 A GB1192665 A GB 1192665A GB 1192665 A GB1192665 A GB 1192665A GB 1101458 A GB1101458 A GB 1101458A
- Authority
- GB
- United Kingdom
- Prior art keywords
- myotic
- pharmaceutical compositions
- local anaesthetics
- synergistic pharmaceutical
- neurotropic drugs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Pharmaceutical preparations comprise at least one of the following:-procaine, tetracaine, lignocaine, cinchocaine, benodaine, pilocarpine and at least one hydrolysis product derived from the acid moiety of a p-amino-benzoic acid ester, e.g. sodium p-amino-benzoate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1192665A GB1101458A (en) | 1965-07-20 | 1965-07-20 | Synergistic pharmaceutical compositions comprising local anaesthetics, myotic and neurotropic drugs |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1192665A GB1101458A (en) | 1965-07-20 | 1965-07-20 | Synergistic pharmaceutical compositions comprising local anaesthetics, myotic and neurotropic drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1101458A true GB1101458A (en) | 1968-01-31 |
Family
ID=9995187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1192665A Expired GB1101458A (en) | 1965-07-20 | 1965-07-20 | Synergistic pharmaceutical compositions comprising local anaesthetics, myotic and neurotropic drugs |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1101458A (en) |
-
1965
- 1965-07-20 GB GB1192665A patent/GB1101458A/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE873326A (en) | ANTI-CANCER AND PREVENTIVE MEDICINE FOR CANCERIOUS METASTASES | |
GB1101458A (en) | Synergistic pharmaceutical compositions comprising local anaesthetics, myotic and neurotropic drugs | |
ATA401872A (en) | Stabilized pharmaceutical composition containing fluvastatin sodium as active ingredient | |
GB1049996A (en) | New medicine with anti-inflammatory and anti-rheumatic activity | |
FR2373561A1 (en) | CORTICOSTEROIDS AND MEDICINAL PRODUCTS CONTAINING THEM | |
CA958643A (en) | Pharmaceutical compositions containing cyclobenzaprine | |
PH12135A (en) | Anthelmintic pharmaceutical preparations containing 4-(4-nitroanilino)-phenylisothiocyanate | |
IL37629A0 (en) | Pharmaceutical compositions comprising a derivative of hydantoin | |
IT1150100B (en) | PROCEDURE FOR THE PRODUCTION OF SAPPONINE PREPARATIONS HAVING A THERAPEUTIC VALUE AND PRODUCTS SO OBTAINED | |
BE887320A (en) | COMPOSITION AND ANTI-INFLAMMATORY MEDICINAL PRODUCT COMPRISING SUCH A COMPOSITION | |
IL29954A0 (en) | Process for the preparation of morpholine derivatives and pharmaceutical compositions containing them | |
IL28811A (en) | 1,3-disubstituted pyrrolidines,their preparation and pharmaceutical compositions containing them | |
IL26620A (en) | 1,2-dihydroquinoline-n-carboxylic and thionocarboxylic acid esters,their preparation and pharmaceutical compositions containing them | |
AU414340B2 (en) | Medicinal compositions for administration to animals and process for administering same | |
AU3469468A (en) | Medicinal compositions for administration to animals and process for administering same | |
BE778421A (en) | BENZENE-SULFONYL-UREES AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES | |
CA707745A (en) | Preparation of a medicinal agent for the treatment of hypercholesterolemia | |
FR2025033A1 (en) | PHENYL-DITHIO-CARBAMIC ACID ESTERS AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES | |
SE7809943L (en) | PHARMACOLOGICAL ACTIVE ESTERS, PREPARATIONS FOR PRODUCTS THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH ASSOCIATIONS | |
GB1099269A (en) | New anti-arteriosclerotic compositions | |
CA726162A (en) | Gastro-intestinal therapeutic compositions containing pantothenic acid and method of administration | |
AU439970B2 (en) | Pharmaceutical compositions forthe treatment of nematode infections | |
IL37700A0 (en) | Pharmaceutical preparations containing a propanolamine derivative and an ethanolamine derivative | |
AU291240B2 (en) | Improvements relating tothe production of pharmaceutical dosage units | |
CA724631A (en) | Therapeutic compositions for oral administration |